-
1
-
-
79955042842
-
Whole-genome sequencing: A step closer to personalized medicine
-
Pasche B, Absher D. Whole-genome sequencing: a step closer to personalized medicine. JAMA. 2011;305(15):1596-1597.
-
(2011)
JAMA
, vol.305
, Issue.15
, pp. 1596-1597
-
-
Pasche, B.1
Absher, D.2
-
2
-
-
84880535720
-
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
-
Green RC, Berg JS, Grody WW, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15(7):565-574.
-
(2013)
Genet Med
, vol.15
, Issue.7
, pp. 565-574
-
-
Green, R.C.1
Berg, J.S.2
Grody, W.W.3
-
3
-
-
84880421555
-
Return of secondary genomic findings vs patient autonomy: Implications for medical care
-
Klitzman R, Appelbaum PS, Chung W. Return of secondary genomic findings vs patient autonomy: implications for medical care. JAMA. 2013;310(4):369-370.
-
(2013)
JAMA
, vol.310
, Issue.4
, pp. 369-370
-
-
Klitzman, R.1
Appelbaum, P.S.2
Chung, W.3
-
4
-
-
84880411296
-
Mandatory extended searches in all genome sequencing: "Incidental findings," patient autonomy, and shared decision making
-
Ross LF, Rothstein MA, Clayton EW. Mandatory extended searches in all genome sequencing: "incidental findings," patient autonomy, and shared decision making. JAMA. 2013;310(4):367-368.
-
(2013)
JAMA
, vol.310
, Issue.4
, pp. 367-368
-
-
Ross, L.F.1
Rothstein, M.A.2
Clayton, E.W.3
-
5
-
-
84885895246
-
Citizens' perspectives on personalized medicine: A qualitative public deliberation study
-
Bombard Y, Abelson J, Simeonov D, Gauvin FP. Citizens' perspectives on personalized medicine: a qualitative public deliberation study. Eur J Hum Genet. 2013.
-
(2013)
Eur J Hum Genet
-
-
Bombard, Y.1
Abelson, J.2
Simeonov, D.3
Gauvin, F.P.4
-
6
-
-
4544245238
-
The "duty to warn" a patient's family members about hereditary disease risks
-
DOI 10.1001/jama.292.12.1469
-
Offit K, Groeger E, Turner S, Wadsworth EA, Weiser MA. The "duty to warn" a patient's family members about hereditary disease risks. JAMA. 2004;292(12):1469-1473. (Pubitemid 39258340)
-
(2004)
Journal of the American Medical Association
, vol.292
, Issue.12
, pp. 1469-1473
-
-
Offit, K.1
Groeger, E.2
Turner, S.3
Wadsworth, E.A.4
Weiser, M.A.5
-
7
-
-
84866441332
-
Risks to relatives in genomic research: A duty to warn?
-
Bombard Y, Offit K, Robson ME. Risks to relatives in genomic research: a duty to warn? Am J Bioeth. 2012;12(10):12-14.
-
(2012)
Am J Bioeth
, vol.12
, Issue.10
, pp. 12-14
-
-
Bombard, Y.1
Offit, K.2
Robson, M.E.3
-
8
-
-
84883856709
-
Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies
-
[published online April 4, 2013]. doi:10.1038/gim.2013.37
-
Goddard KA, Whitlock EP, Berg JS, et al. Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies [published online April 4, 2013]. Genet Med. doi:10.1038/gim.2013.37.
-
Genet Med
-
-
Goddard, K.A.1
Whitlock, E.P.2
Berg, J.S.3
|